Data as of Apr 17
| +0.86 / +1.07%|
The 15 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 78.00, with a high estimate of 90.00 and a low estimate of 60.00. The median estimate represents a -4.05% decrease from the last price of 81.29.
The current consensus among 22 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.